Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Weight-Loss Drugs Boost Case for Pharma ETFs By: ETF Trends April 30, 2024 at 08:00 AM EDT Weight-loss drugs, including Ozempic, are reshaping consumer habits. Additionally, they are providing some ballast to what’s recently been a sluggish healthcare investment thesis. Tactical investors know that when it comes to drugs or therapies, regardless of underlying usage case, it’s best to play related developments with assets that seize upon those themes. That’s likely one [...] The post Weight-Loss Drugs Boost Case for Pharma ETFs appeared first on ETF Trends . Read More >> Related Stocks: VanEck Pharmaceutical ETF Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Weight-Loss Drugs Boost Case for Pharma ETFs By: ETF Trends April 30, 2024 at 08:00 AM EDT Weight-loss drugs, including Ozempic, are reshaping consumer habits. Additionally, they are providing some ballast to what’s recently been a sluggish healthcare investment thesis. Tactical investors know that when it comes to drugs or therapies, regardless of underlying usage case, it’s best to play related developments with assets that seize upon those themes. That’s likely one [...] The post Weight-Loss Drugs Boost Case for Pharma ETFs appeared first on ETF Trends . Read More >> Related Stocks: VanEck Pharmaceutical ETF
